[Juvenile systemic lupus erythematosus with unusual manifestation of lupus-associated panniculitis].
Juvenile systemic lupus erythematosus (JSLE) is a rare multisystem autoimmune disease with broad heterogeneity of clinical manifestations. Diagnosing JSLE is often very challenging. This life-threatening, unpredictable, and relapsing disease, which may affect various organ systems, requires interdisciplinary, lifelong care. Here, we report the case of a 13-year-old patient with JSLE suffering from recurrent arthralgia, lupus panniculitis, and rashes that were successfully treated with hydroxychloroquine and prednisolone.
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
H
H
Hashemie
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
N
N
Klossowski
Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
P T
PT
Oommen
Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
J
J
Neubert
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
B
B
Homey
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
N-P
NP
Hoff
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
J
J
Reifenberger
Hautklinik, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. stephan.meller@uni-duesseldorf.de.
S
S
Meller
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D015435:Panniculitis, Lupus Erythematosus / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D011239:Prednisolone / Q000008:administration & dosage*; D012008:Recurrence; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D006886:Hydroxychloroquine; D011239:Prednisolone
ACR criteria; Autoimmune diseases; Combination therapy; Hydroxychloroquine; Prednisolone